dimethyl fumarate tablets
dimethyl fumarate
Skilarence 30 mg gastro-resistant tablets
Skilarence is indicated for the treatment of moderate to severe plaque psoriasis in adults in need of systemic medicinal therapy.
Facts about dimethyl fumarate tablets
DISEASE INDICATIONS-Psoriasis
MANUFACTURER-Almirall, S.A.
USAGE-Oral
Delayed-release capsules: 120 mg and 240 mg
MEDICINE APPROVED BY-European Medical Agency (EMA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)
Access the best support services globally
If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “dimethyl fumarate tablets” based on the information you provide.
Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.
Contact Info
CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.
MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398
EMAIL ID:
info@indianpharmanetwork.co.in
FAX NUMBER:
+91-11-26532129
Query For dimethyl fumarate tablets
Approved accessible "dimethyl fumarate tablets"
Dimethyl fumarate is used to treat psoriasis in an oral formulation mixed with related compounds as well as in pure oral formulations. Since 2013, it has been used to treat adults with relapsing multiple sclerosis (trade name Tecfidera. In 2017, a new oral formulation of DMF (trade name Skilarence) was approved by the European Medicines Agency (EMA) for use in Europe as a treatment for moderate-to-severe plaque psoriasis. DMF is thought to have immunomodulatory properties without causing significant immunosuppression.
In Germany, dimethyl fumarate is marketed for the treatment of psoriasis and is available as an oral formulation mixed with related compounds (Fumaderm); in the UK, it is available as a pure oral formulation (Skilarence). It is also available in the US as an oral formulation (Tecfidera) to treat adults with relapsing multiple sclerosis. A 2015 Cochrane systematic review found moderate quality evidence of a reduction in the number of people with relapsing remitting MS that had relapses over a two-year treatment period with dimethyl fumarate versus placebo, as well as low quality evidence of a reduction in worsening disability, and an overall need for higher quality studies with longer follow-up.
How can 1 go about obtaining dimethyl fumarate tablets?
If dimethyl fumarate tablets are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj).
- TECFIDERA (dimethyl fumarate) delayed-release capsules, for oral use Initial U.S. Approval: 2013
- Skilarence 120 mg gastro-resistant tablets
References
- [FDA]: Tecfidera (dimethyl fumarate) [PDF] Biogen, March 2013.
- [EMA]: Tecfidera (dimethyl fumarate) [PDF] Biogen Netherlands, January 2014.
- [TGA]: Tecfidera (dimethyl fumarate) [PDF] Biogen Australia, July 2013.
- [Health Canada]: Tecfidera (dimethyl fumarate) [PDF] Biogen Canada, February 2014.
Indian Pharma Network (IPN), New Delhi. India
Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa
Indian Pharma Network
Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398
Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in